Acquisition to provide impetus to Sequent Scientific's human API business
The European drug quality regulatory approval will further enhance the company's sales in the region
The loan will help Jubilant Life Sciences increase focus on the pharmaceutical sector and strengthen its generic drug manufacturing facilities in India
These drugs will be launched in the domestic market by 2015
The two partners plan to launch their first product in 2017
Since 2007, Bristol-Myers Squibb has been collaborating with Syngene and Biocon Ltd for drug discovery and development in India
The company has received approval to manufacture the drug at its formulation facility in Hyderabad
The plant, located at Taloja (Maharashtra), manufactures APIs and intermediates